OCA at 07:42, 1 May 2024

OCA — Wed, 01 May 2024 07:42:36 GMT

←Older revision		Revision as of 07:42, 1 May 2024
Line 1:		Line 1:

-	====	+	==Crystal structure of Thrombin in complex with compound30==
-	<StructureSection load='6zuu' size='340' side='right'caption='[[6zuu]]' scene=''>	+	<StructureSection load='6zuu' size='340' side='right'caption='[[6zuu]], [[Resolution\|resolution]] 1.94Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6zuu]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Hirudo_medicinalis Hirudo medicinalis] and [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6ZUU OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6ZUU FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=6zuu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6zuu OCA], [~~http~~://pdbe.org/6zuu PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=6zuu RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/6zuu PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=6zuu ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.94Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=QQN:[2-[(3-chlorophenyl)methylamino]-4-methoxy-1,3-benzoxazol-6-yl]-[(3~{R},4~{R})-3-methyl-4-oxidanyl-piperidin-1-yl]methanone'>QQN</scene>, <scene name='pdbligand=TYS:O-SULFO-L-TYROSINE'>TYS</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6zuu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6zuu OCA], [https://pdbe.org/6zuu PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6zuu RCSB], [https://www.ebi.ac.uk/pdbsum/6zuu PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6zuu ProSAT]</span></td></tr>
	</table>		</table>
		+	== Disease ==
		+	[https://www.uniprot.org/uniprot/THRB_HUMAN THRB_HUMAN] Defects in F2 are the cause of factor II deficiency (FA2D) [MIM:[https://omim.org/entry/613679 613679]. It is a very rare blood coagulation disorder characterized by mucocutaneous bleeding symptoms. The severity of the bleeding manifestations correlates with blood factor II levels.<ref>PMID:14962227</ref> <ref>PMID:6405779</ref> <ref>PMID:3771562</ref> <ref>PMID:3567158</ref> <ref>PMID:3801671</ref> <ref>PMID:3242619</ref> <ref>PMID:2719946</ref> <ref>PMID:1354985</ref> <ref>PMID:1421398</ref> <ref>PMID:1349838</ref> <ref>PMID:7865694</ref> <ref>PMID:7792730</ref> Genetic variations in F2 may be a cause of susceptibility to ischemic stroke (ISCHSTR) [MIM:[https://omim.org/entry/601367 601367]; also known as cerebrovascular accident or cerebral infarction. A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors.<ref>PMID:15534175</ref> Defects in F2 are the cause of thrombophilia due to thrombin defect (THPH1) [MIM:[https://omim.org/entry/188050 188050]. It is a multifactorial disorder of hemostasis characterized by abnormal platelet aggregation in response to various agents and recurrent thrombi formation. Note=A common genetic variation in the 3-prime untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of venous thrombosis. Defects in F2 are associated with susceptibility to pregnancy loss, recurrent, type 2 (RPRGL2) [MIM:[https://omim.org/entry/614390 614390]. A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions.<ref>PMID:11506076</ref>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/THRB_HUMAN THRB_HUMAN] Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing.<ref>PMID:2856554</ref>
		+
		+	==See Also==
		+	*[[Hirudin 3D structures\|Hirudin 3D structures]]
		+	*[[Thrombin 3D Structures\|Thrombin 3D Structures]]
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Hirudo medicinalis]]
		+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Z-disk~~]]	+	[[Category: Schafer M]]

OCA at 06:22, 7 October 2020

OCA — Wed, 07 Oct 2020 06:22:01 GMT

←Older revision		Revision as of 06:22, 7 October 2020
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6zuu ~~is ON HOLD~~	+	====
-		+	<StructureSection load='6zuu' size='340' side='right'caption='[[6zuu]]' scene=''>
-	~~Authors~~: ~~Schafer~~, M.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id= OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol= FirstGlance]. <br>
-	~~Description: Crystal structure of Thrombin in complex with compound30~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6zuu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6zuu OCA], [http://pdbe.org/6zuu PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6zuu RCSB], [http://www.ebi.ac.uk/pdbsum/6zuu PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6zuu ProSAT]</span></td></tr>
-	[[Category: ~~Unreleased~~ Structures]]	+	</table>
-	[[Category: ~~Schafer, M~~]]	+	__TOC__
		+	</StructureSection>
		+	[[Category: Large Structures]]
		+	[[Category: Z-disk]]

OCA: Protected "6zuu" [edit=sysop:move=sysop]

OCA — Wed, 29 Jul 2020 09:38:08 GMT

Protected "6zuu" [edit=sysop:move=sysop]

←Older revision

Revision as of 09:38, 29 July 2020

OCA: New page: '''Unreleased structure''' The entry 6zuu is ON HOLD Authors: Schafer, M. Description: Crystal structure of Thrombin in complex with compound30 Category: Unreleased Structures [[Ca...

OCA — Wed, 29 Jul 2020 09:38:07 GMT

New page: '''Unreleased structure''' The entry 6zuu is ON HOLD Authors: Schafer, M. Description: Crystal structure of Thrombin in complex with compound30 Category: Unreleased Structures [[Ca...

New page

'''Unreleased structure'''

The entry 6zuu is ON HOLD

Authors: Schafer, M.

Description: Crystal structure of Thrombin in complex with compound30
[[Category: Unreleased Structures]]
[[Category: Schafer, M]]

6zuu - Revision history

OCA at 07:42, 1 May 2024

OCA at 06:22, 7 October 2020

OCA: Protected "6zuu" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 6zuu is ON HOLD Authors: Schafer, M. Description: Crystal structure of Thrombin in complex with compound30 Category: Unreleased Structures [[Ca...